Approval Is Not the Finish Line: Navigating Continuity of Access When Products Are Commercialised
2:45 pm - Wednesday 21st October 2026
- Navigating regulatory pathways and reimbursement gaps as patients move from Early Access Programs into commercial access
- Planning for supply, governance and patient transition to minimise disruption and maintain continuity of treatment
- Building continuity of access into launch planning before approval, creating a clear pathway for patients already receiving treatment
